Jun 03, 2025, 16:42
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-listing
Jun 03, 2025, 16:42
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-listing
Jun 02, 2025, 18:50
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
Jun 02, 2025, 18:50
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
May 27, 2025, 10:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-listing
May 27, 2025, 10:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-listing
May 15, 2025, 10:30
News
IR
English
Regulatory
Listing Regulation
Corporate Action
Prospectus
mfn-cus-disclaimer
May 15, 2025, 10:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Action
Prospectus
mfn-cus-disclaimer
May 12, 2025, 13:35
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Raport bolagsstämman
May 07, 2025, 14:20
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
May 06, 2025, 18:20
News
IR
English
Correction
Regulatory
Listing Regulation
Report
Annual
May 06, 2025, 13:40
News
IR
English
Regulatory
Listing Regulation
Report
Annual
Apr 25, 2025, 08:15
News
IR
Swedish
Regulatory
Listing Regulation
Report
Annual
Apr 24, 2025, 15:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Apr 24, 2025, 15:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Apr 24, 2025, 08:55
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Apr 24, 2025, 08:37
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
Apr 24, 2025, 08:37
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 70 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
Interim CEO
Anders Månsson
Mail: anders.mansson@iconovo.se
Press releases
Follow us on Linkedin
